Yi Tang, MD, PhD is a Chief Neurologist for the Department of Neurology, Innovation Center for Neurological Disorders at Xuanwu Hospital Capital Medical University in China. After graduating from Peking Union Medical College with a double degree, MD and PhD, he completed his residency in neurology at Xuanwu Hospital. Continuing his education overseas, he accepted a post-doctoral fellowship at Cornell University School of Medicine/New York Presbyterian Hospital. Currently Dr. Tang serves as the Deputy Director for the Key Laboratory Neurodegenerative Diseases for the Ministry of Education in China.
Dr. Tang has authored numerous internationally accredited papers and 4 book chapters. Dedicated to research, he has been the principal investigator of 4 national and 10 provincial clinical trials in China. His primary research focus is identifying new biomarkers for Alzheimer’s disease, participating in the development of internet-based, computerized, multi-cognitive domain and utilizing adaptive cognitive training programs. Recognized internationally, Dr. Tang pioneered targeted cognitive training research, which included early-stage patients with vascular cognitive impairment. Hi participation in the Cog-VACCINE study helped clarify the effect of computerized cognitive training on the overall cognitive function and language function of early-onset patients with vascular cognitive impairment. Dr. Tang participates in multiple societies and committees in China and internationally. He is currently a Senior Editor in The Journal of The Alzheimer’s Association by Elsevier; Alzheimer’s & Dementia Magazine. In 2016, he was awarded Outstanding Chinese Young Neurologist and Dr. Tang continues to globally impact the diagnosis and treatment of cognitive impairment. AMPSAA is honored to have Dr. Tang as a co-chairman at the 1st China-US International Medical Summit (CIMS) – Neuroscience & Geriatrics Symposium 2019 in Beijing, China.